Mannkind (MNKD) Free Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.35% |
| Dec 31, 2025 | -131.95% |
| Sep 30, 2025 | 209.74% |
| Jun 30, 2025 | 216.79% |
| Mar 31, 2025 | -146.46% |
| Dec 31, 2024 | 9.16% |
| Sep 30, 2024 | 10,920.83% |
| Jun 30, 2024 | -97.62% |
| Mar 31, 2024 | -77.59% |
| Dec 31, 2023 | -28.31% |
| Sep 30, 2023 | 255.63% |
| Jun 30, 2023 | -1,471.45% |
| Mar 31, 2023 | 84.97% |
| Dec 31, 2022 | 68.73% |
| Sep 30, 2022 | 6.39% |
| Jun 30, 2022 | -25.08% |
| Mar 31, 2022 | -217.71% |
| Dec 31, 2021 | 63.83% |
| Sep 30, 2021 | 6.36% |
| Jun 30, 2021 | -57.98% |
| Mar 31, 2021 | -5,131.68% |
| Dec 31, 2020 | 98.05% |
| Sep 30, 2020 | -240.69% |
| Jun 30, 2020 | 64.87% |
| Mar 31, 2020 | -50.64% |
| Dec 31, 2019 | 85.49% |
| Sep 30, 2019 | -154.16% |
| Jun 30, 2019 | -70.65% |
| Mar 31, 2019 | -147.49% |
| Dec 31, 2018 | 279.52% |
| Sep 30, 2018 | 48.73% |
| Jun 30, 2018 | -25.40% |
| Mar 31, 2018 | 27.79% |
| Dec 31, 2017 | -28.84% |
| Sep 30, 2017 | -16.15% |
| Jun 30, 2017 | -335.50% |
| Mar 31, 2017 | 166.71% |
| Dec 31, 2016 | 44.73% |
| Sep 30, 2016 | -100.46% |
| Jun 30, 2016 | 63.92% |
| Mar 31, 2016 | -39.51% |
| Dec 31, 2015 | -8.25% |
| Sep 30, 2015 | 5.46% |
| Jun 30, 2015 | -1,788.67% |
| Mar 31, 2015 | 97.09% |
| Dec 31, 2014 | -144.85% |
| Sep 30, 2014 | 386.56% |
| Jun 30, 2014 | 17.51% |
| Mar 31, 2014 | 4.52% |
| Dec 31, 2013 | -21.35% |
| Sep 30, 2013 | -10.93% |
| Jun 30, 2013 | 10.78% |
| Mar 31, 2013 | -18.90% |
| Dec 31, 2012 | 18.09% |
| Sep 30, 2012 | -36.75% |
| Jun 30, 2012 | 23.37% |
| Mar 31, 2012 | -59.97% |
| Dec 31, 2011 | 44.01% |
| Sep 30, 2011 | 10.35% |
| Jun 30, 2011 | -24.96% |
| Mar 31, 2011 | 23.80% |
| Dec 31, 2010 | -17.87% |